Sino Biopharmaceutical Limited (SBHMY)
OTCMKTS · Delayed Price · Currency is USD
20.16
0.00 (0.00%)
At close: Aug 27, 2025
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of $19.83 billion as of September 12, 2025. Its market cap has increased by 160.31% in one year.
Market Cap
19.83B
Enterprise Value
20.47B
Revenue
4.27B
Ranking
n/a
PE Ratio
36.70
Stock Price
$20.16
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 42.32M to 19.83B, an increase of 46,763.42%. That is a compound annual growth rate of 27.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 19.38B | 158.38% |
| Dec 31, 2024 | 7.50B | -8.23% |
| Dec 29, 2023 | 8.17B | -24.55% |
| Dec 30, 2022 | 10.83B | -17.52% |
| Dec 31, 2021 | 13.13B | -27.75% |
| Dec 31, 2020 | 18.18B | 3.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 739.37M |
| Tian'an Technology Group | 675.94M |
| Glass House Brands | 608.81M |
| CytoDyn | 424.27M |
| Northwest Biotherapeutics | 378.39M |
| American Oncology Network | 353.52M |